STAT3 and hepatocellular carcinoma: In addition, ectopic expression of STAT3 not only restored GSH levels (Figure 4C), but also reduced the burden of lipid ROS associated with sorafenib treatment (Figure 4D), and rescued HCC cells from ferroptotic cell death (Figure 4A).